BCX7353, a Potent Inhibitor of Plasma Kallikrein, Shows Sustained Maximal Enzyme Inhibition When Dosed Orally Once Daily: Results from a Phase I Trial in Healthy Subjects

Autor: Cornpropst, Melanie, Dobo, Sylvia, Collier, Jo, Rose, Angela, Wilson, Ramanda, Babu, Y.S., Collis, Phil, Sheridan, William
Zdroj: In The Journal of Allergy and Clinical Immunology February 2016 137(2) Supplement:AB401-AB401
Databáze: ScienceDirect
Externí odkaz: